Nadira Duraković

Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide

Christopher G. Kanakry, Javier Bolaños‐Meade, Yvette L. Kasamon et al. · Blood · 2017 · 88 citations · Full text

Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties

Peter Dreger, Mauricette Michallet, Paul Bosman et al. · Bone Marrow Transplantation · 2018 · 71 citations

Hematological Malignancy, Lymphoid Neoplasia, Cell Therapy +11

Efficacy and Safety of Colistin in the Treatment of Infections Caused by Multidrug-resistant Pseudomonas aeruginosa in Patients with Hematologic Malignancy: A Matched Pair Analysis

Nadira Duraković, Vedran Radojčić, Ana Boban et al. · Internal Medicine · 2011 · 45 citations · Full text

Influence of Blood Count, Cardiovascular Risks, Inherited Thrombophilia, and JAK2 V617F Burden Allele on Type of Thrombosis in Patients With Philadelphia Chromosome Negative Myeloproliferative Neoplasms

Ivana Horvat, Ana Boban, Renata Zadro et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 40 citations

Hematological Malignancy, Thrombosis, Blood Count +10

Host-Derived Langerhans Cells Persist after MHC-Matched Allografting Independent of Donor T Cells and Critically Influence the Alloresponses Mediated by Donor Lymphocyte Infusions

Nadira Duraković, Karl Bezak, Mario Škarica et al. · The Journal of Immunology · 2006 · 35 citations · Full text